Feasibility of periprocedural decision on the administration of intravenous contrast media in MRI for endometriosis
article
OA: closed
CC0
⤵ 2 in-corpus citations
AI-generated summary
This study investigated the feasibility of making on-the-spot decisions about using intravenous contrast media during MRI scans for endometriosis.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
PURPOSE: To assess the feasibility of a periprocedural decision on the administration of intravenous contrast media in MRI for endometriosis and to evaluate the frequency and reasons of contrast administrations, the corresponding MRI diagnoses, and outcome.
METHODS: In this retrospective, descriptive cross-sectional single-center study all patients were included, who received a pelvic MRI for evaluation of endometriosis between April 2021 and February 2023. Frequency and reasons of optional intravenous administration of contrast media, corresponding MRI diagnoses and clinical outcome data were noted after re-review of all images, review of radiology reports and review of patients' medical records. The decision on the administration of intravenous contrast media had been made by experienced radiologists, depending on the findings of the non-contrast sequences and the presence of ancillary questions.
RESULTS: 303 consecutive patients (mean age, 33.4 years +/- 8.3 [standard deviation]) were evaluated. Periprocedural decision on the administration of intravenous contrast media had been made in all cases. For 219/303 (72.3%) patients, it was decided after review of the non-contrast sequences and exclusion of ancillary questions that contrast administration was not required. 84/303 (27.7%) patients received contrast media, and the most frequent reasons were indeterminate ovarian lesion (41/84 cases, 48.8%) or suspicion of pelvic venous congestion syndrome (26/84 cases, 31.0%). No relevant differences in patient outcomes could be noted (non-contrast/contrast MRI).
CONCLUSIONS: A periprocedural decision on the administration of contrast media in MRI for endometriosis is feasible with little effort. It allows the administration of contrast media to be avoided in most cases. If the administration of contrast media is deemed necessary, repeat examinations can be avoided.
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (23)
- Deep pelvic endometriosis: Limited additional diagnostic value of postcontrast in comparison with conventional MR images via openalex
- Diagnosis of colorectal endometriosis: contribution of contrast enhanced MR-colonography via openalex
- Endometriosis: A multimodal imaging review via openalex
- Endometriosis and cancer: a systematic review and meta-analysis via openalex
- Endometriosis-associated Malignancy via openalex
- Endometriosis MRI lexicon: consensus statement from the society of abdominal radiology endometriosis disease-focused panel via openalex
- European society of urogenital radiology (ESUR) guidelines: MR imaging of pelvic endometriosis via openalex
- Management of endometriosis via openalex
- MRI for the diagnosis and staging of deeply infiltrating endometriosis: a national survey of BSGE accredited endometriosis centres and review of the literature via openalex
- MRI technique for the preoperative evaluation of deep infiltrating endometriosis: current status and protocol recommendation via openalex
- The #Enzian classification: A comprehensive non‐invasive and surgical description system for endometriosis via openalex
- W2994207972 via openalex
- W3012456945 via openalex
- W2918190467 via openalex
- W2884379420 via openalex
- W3117176708 via openalex
- W2969729739 via openalex
- W3124768173 via openalex
- W3134619991 via openalex
- W4206742016 via openalex
- W4211081176 via openalex
- W4214754424 via openalex
- W2947728671 via openalex
Cited by (2)
Source provenance
- europepmc
- last seen: 2026-06-28T06:08:18.748782+00:00
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
- pubmed
- last seen: 2026-06-28T06:07:13.548591+00:00
License: CC0
· commercial use OK